Home > Insider Trading > Filing (0001225208-21-013881)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1725474	Angela Hwang	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Group President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-11-12	800	$49.61	25,371	No	4	S	Direct
Common Stock	Disposition	2021-11-12	3,412	$49.62	21,959	No	4	S	Direct
Common Stock	Disposition	2021-11-12	10,646	$49.59	11,313	No	4	S	Direct
Common Stock	Disposition	2021-11-12	11,312	$49.60	1	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock Units SSP	Acquisiton	2021-11-12	18,098	$49.73	18,098	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,576			No	4	I	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	27,634	Indirect	By Rule 16b-3 Plan
Common Stock	8,532	Indirect	By Spouse

Footnotes

The reporting person disclaims beneficial ownership of the shares held by spouse.
Each unit represents one phantom share of common stock.
This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.